This company has been marked as potentially delisted and may not be actively trading. Terns Pharmaceuticals (TERN) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Terns Pharmaceuticals Earnings Summary Terns Pharmaceuticals posted Q4 2025 earnings on March 30, 2026, reporting an EPS of -$0.24, which topped the consensus estimate of -$0.30 by $0.06. With a trailing EPS of -$1.03, Terns Pharmaceuticals' earnings are expected to decrease next year, from ($1.22) to ($1.67) per share. Q4 2025 Earnings ResourcesQ4 2025 Earnings Report Annual Report (10-K)Powered by Latest Q4 Earnings DateMar. 30EstimatedConsensus EPS (Mar. 30) -$0.30 Actual EPS (Mar. 30) -$0.24 Beat By $0.06 Get Terns Pharmaceuticals Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terns Pharmaceuticals and other key companies, straight to your inbox. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataTERN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Terns Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20262-$0.32-$0.29-$0.31Q2 20262-$0.34-$0.30-$0.32Q3 20261-$0.36-$0.36-$0.36Q4 20261-$0.40-$0.40-$0.40 Terns Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails3/30/2026Q4 2025-$0.30-$0.24+$0.06-$0.24--11/10/2025Q3 2025-$0.30-$0.27+$0.03-$0.27--8/5/2025Q2 2025-$0.28-$0.26+$0.02-$0.26--5/8/2025Q1 2025-$0.29-$0.26+$0.03-$0.26--3/20/2025Q4 2024-$0.30-$0.24+$0.06-$0.24--11/12/2024--$0.33-$0.28+$0.05-$0.28--8/5/2024--$0.35-$0.31+$0.04-$0.31-- Data powered by Fiscal.ai. Terns Pharmaceuticals Earnings - Frequently Asked Questions When did Terns Pharmaceuticals announce their last quarterly earnings? Terns Pharmaceuticals (NASDAQ:TERN) last announced its quarterly earning data on Monday, March 30, 2026. Learn more on TERN's earnings history. Did Terns Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, Terns Pharmaceuticals (NASDAQ:TERN) reported ($0.24) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.06. Learn more on analysts' earnings estimate vs. TERN's actual earnings. How much profit does Terns Pharmaceuticals generate each year? Terns Pharmaceuticals (NASDAQ:TERN) has a recorded net income of -$96.21 million. TERN has generated -$1.03 earnings per share over the last four quarters. What is Terns Pharmaceuticals' EPS forecast for next year? Terns Pharmaceuticals' earnings are expected to decrease from ($1.22) per share to ($1.67) per share in the next year. More Earnings Resources from MarketBeat Related Companies Insmed Earnings Results BioNTech Earnings Results Roivant Sciences Earnings Results Viatris Earnings Results Moderna Earnings Results Genmab A/S Earnings Results Ascendis Pharma A/S Earnings Results Regencell Bioscience Earnings Results BridgeBio Pharma Earnings Results Summit Therapeutics Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Workday Validates AI Flywheel: Stock Price Recovery BeginsOverextended, e.l.f. Beauty Is Primed to Rebound in Back HalfDeere Beats Q2 Estimates, But Ag Weakness Weighs on OutlookNVIDIA Price Pullback? Don’t Count on It, Business Is AcceleratingMeta Platforms 10% Layoff Raises a Bigger Question About AI SpendingBiogen Stock Slides After Trial Miss, But Analysts Stay Bullish This page (NASDAQ:TERN) was last updated on 5/24/2026 by MarketBeat.com Staff. From Our PartnersYour computer is about to become a museum pieceFuturist George Gilder - who predicted the smartphone years before the iPhone launched - believes today's AI d...Eagle Publishing | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredFrom the man who predicted 2008 crash…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredPH: Do THESE 4 things to your bank account now …In a few short months, the US government could gain unprecedented powers over personal bank accounts - includi...Weiss Ratings | SponsoredJune 12: Elon Musk’s “Day-One Retirement Plan.”SpaceX is expected to go public on June 12 - and for the first time, everyday investors may have a way in befo...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
